Executive Summary
The PTAB denied Innoscience America's petition to institute IPR against Infineon Technologies regarding patent 9070755. The Board found that factors favoring discretionary denial, such as overlap with a parallel ITC investigation, outweighed arguments for institution.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Innoscience America, Inc. et al. vs Infineon Technologies Americas Corp. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Samsung Electronics Co., Ltd. et al.vsHeadwater Research LLC
The Director denied institution of an Inter Partes Review, vacating the Board's decision and favoring Headwater Research LLC over Samsung Electronics Co., Ltd. based on procedural timing factors.
Lenovo (United States) Inc. et al.vsHeadwater Research LLC
Lenovo and Motorola challenged U.S. Patent No. 9,198,076, arguing that its claims related to power management and network prioritization are obvious. The petitioners assert that combining prior art references like Rao and Araujo with others provides predictable improvements in device functionality and battery longevity.
Tessell, Inc.vsNutanix, Inc.
Tessell, Inc. successfully convinced the PTAB to institute IPR proceedings against Nutanix, Inc., regarding database provisioning technology. The Board found that Tessell demonstrated a reasonable likelihood of prevailing on obviousness grounds over multiple prior art combinations.
Google LLC et al.vsCerence Operating Company et al.
The PTAB denied institution of an IPR filed by Google and Samsung against Cerence regarding voice command detection methods. The denial was based on the advanced stage of a parallel district court litigation, making institutional review inefficient.
MIM Software Inc. et al.vsProgenics Pharmaceuticals, Inc. et al.
The PTAB denied MIM Software's request to institute IPR against Progenics Pharmaceuticals regarding a medical image analysis patent. The denial was based on Petitioner's failure to properly construe the key term 'risk map,' proposing multiple ambiguous definitions without adequate justification.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.